Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Sell
2,904
-205
-7% -$70.2K 0.24% 67
2026
Q1
$1.09M Buy
3,109
+24
+0.8% +$8.56K 0.29% 61
2025
Q4
$1.01M Buy
3,085
+54
+2% +$17.1K 0.27% 64
2025
Q3
$855K Buy
3,031
+60
+2% +$17.4K 0.23% 73
2025
Q2
$830K Buy
2,971
+51
+2% +$14.4K 0.24% 70
2025
Q1
$910K Sell
2,920
-269
-8% -$79.4K 0.3% 64
2024
Q4
$831K Buy
3,189
+81
+3% +$24K 0.26% 68
2024
Q3
$1M Buy
3,108
+18
+0.6% +$5.89K 0.29% 65
2024
Q2
$965K Buy
3,090
+269
+10% +$79K 0.31% 63
2024
Q1
$802K Hold
2,821
0.27% 68
2023
Q4
$813K Hold
2,821
0.3% 63
2023
Q3
$761K Sell
2,821
-28
-1% -$6.99K 0.3% 64
2023
Q2
$633K Buy
2,849
+19
+0.7% +$4.41K 0.25% 70
2023
Q1
$684K Hold
2,830
0.3% 62
2022
Q4
$743K Buy
+2,830
New +$759K 0.39% 59

Other funds holding AMGN

Carr Financial Group's AMGN Position: Q2 2026 in Review

Carr Financial Group reduced its Amgen (AMGN) stake by 6.6% in Q2 2026, selling an estimated $70.2K and leaving 2,904 shares worth $1.05M. The position accounts for 0.24% of the portfolio, ranked #67.

Carr Financial Group first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.09M in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Carr Financial Group held 2,904 shares of Amgen worth $1.05M as of Q2 2026.
  • Carr Financial Group sold 205 Amgen shares in Q2 2026, an estimated $70.2K.
  • Amgen made up 0.24% of Carr Financial Group's portfolio in Q2 2026, its #67 holding.
  • Carr Financial Group first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • Carr Financial Group's Amgen position peaked at $1.09M in Q1 2026.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Carr Financial Group's 13F filing for Q2 2026, filed 6 Aug 2026.